Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17
HDN attributed to the rare Rh variants has become more and more significant caused by anti‐D, but the compatible blood is usually very difficult to obtain when exchange transfusion is required. We treated a 10‐hour neonate of O, D + C + c − E − e + blood group with severe HDN due to anti‐Rh17 with l...
Gespeichert in:
| Veröffentlicht in: | Transfusion medicine (Oxford, England) England), 2010-02, Vol.20 (1), p.66-69 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 69 |
|---|---|
| container_issue | 1 |
| container_start_page | 66 |
| container_title | Transfusion medicine (Oxford, England) |
| container_volume | 20 |
| creator | Li, Bi-juan Jiang, Yuan-jun Yuan, Fen Ye, Hong-xing |
| description | HDN attributed to the rare Rh variants has become more and more significant caused by anti‐D, but the compatible blood is usually very difficult to obtain when exchange transfusion is required. We treated a 10‐hour neonate of O, D + C + c − E − e + blood group with severe HDN due to anti‐Rh17 with least incompatible blood typed O, D + C − c + E + e −. The neonatal hemolysis was relieved obviously and bilirubin was reduced gradually after exchange transfusion. The infant was discharged in good health 13 days after birth with 135.0 g/L, 28.0 μmol/L and 10.7 μmol/L of Hb, total bilirubin and direct bilirubin, respectively. No sequelae were observed in a three‐year follow‐up. The result suggesting that the least incompatible blood is an alternative choice for exchange transfusion in severe HDN due to anti‐Rh17 in case that Rh17 antigen‐negative blood is unavailable. |
| doi_str_mv | 10.1111/j.1365-3148.2009.00946.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733867984</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733867984</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4056-fde37b5c4ba765d1f58e1bb70c0ac4d67606f54fc335f9ee096e4aab25bf73643</originalsourceid><addsrcrecordid>eNqNkM1u3CAURlHUKpmmeYWIXVZ2wRiwpWyqdJK0SX9UpeoSAb5kmNpmCnYz8_a1O6NkW6QrkPjOd6WDEKYkp9N5t84pEzxjtKzygpA6n6YU-fYILZ4_XqEFqXmVSS6rE_QmpTUhlBV1cYxOaC0LXpNigbrl1q50_wh4iLpPbkw-9Dg43IJOA_a9Dd1GD960gE0bQoNdiDjBH4iAV9CFdjd4ixufpjzM4LAC3MOTCbHHzTj1Bqz7wWffV1S-Ra-dbhOcHe5T9ON6-XB1m91_vfl49f4-syXhInMNMGm4LY2WgjfU8QqoMZJYom3ZCCmIcLx0ljHuagBSCyi1NgU3TjJRslN0se_dxPB7hDSozicLbat7CGNSkrFKyLqak9U-aWNIKYJTm-g7HXeKEjW7Vms1K1WzUjW7Vv9cq-2Enh-WjKaD5gU8yJ0Cl_vAk29h99_F6uHzcnpMeLbHfRpg-4zr-EsJySRXP7_cKPLt0-3d3Qeprtlfv72dwg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733867984</pqid></control><display><type>article</type><title>Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Li, Bi-juan ; Jiang, Yuan-jun ; Yuan, Fen ; Ye, Hong-xing</creator><creatorcontrib>Li, Bi-juan ; Jiang, Yuan-jun ; Yuan, Fen ; Ye, Hong-xing</creatorcontrib><description>HDN attributed to the rare Rh variants has become more and more significant caused by anti‐D, but the compatible blood is usually very difficult to obtain when exchange transfusion is required. We treated a 10‐hour neonate of O, D + C + c − E − e + blood group with severe HDN due to anti‐Rh17 with least incompatible blood typed O, D + C − c + E + e −. The neonatal hemolysis was relieved obviously and bilirubin was reduced gradually after exchange transfusion. The infant was discharged in good health 13 days after birth with 135.0 g/L, 28.0 μmol/L and 10.7 μmol/L of Hb, total bilirubin and direct bilirubin, respectively. No sequelae were observed in a three‐year follow‐up. The result suggesting that the least incompatible blood is an alternative choice for exchange transfusion in severe HDN due to anti‐Rh17 in case that Rh17 antigen‐negative blood is unavailable.</description><identifier>ISSN: 0958-7578</identifier><identifier>EISSN: 1365-3148</identifier><identifier>DOI: 10.1111/j.1365-3148.2009.00946.x</identifier><identifier>PMID: 19725902</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Blood Component Transfusion - methods ; Blood Group Incompatibility - drug therapy ; Blood Group Incompatibility - immunology ; Blood Grouping and Crossmatching ; Erythrocyte Transfusion ; exchange transfusion ; Female ; HDN ; Humans ; Hydrops Fetalis - immunology ; Hydrops Fetalis - therapy ; Hyperbilirubinemia, Neonatal - etiology ; Hyperbilirubinemia, Neonatal - radiotherapy ; Hyperbilirubinemia, Neonatal - therapy ; Immunoglobulins, Intravenous - therapeutic use ; Immunosuppressive Agents - therapeutic use ; Infant, Newborn ; Isoantibodies - immunology ; least incompatible blood ; Leukocyte Reduction Procedures ; Male ; Methylprednisolone - therapeutic use ; Plasma ; Pregnancy ; Rh Isoimmunization ; Rh-Hr Blood-Group System - immunology ; Rho(D) Immune Globulin ; Ultraviolet Therapy ; Young Adult</subject><ispartof>Transfusion medicine (Oxford, England), 2010-02, Vol.20 (1), p.66-69</ispartof><rights>2009 The Authors. Journal compilation © 2009 British Blood Transfusion Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4056-fde37b5c4ba765d1f58e1bb70c0ac4d67606f54fc335f9ee096e4aab25bf73643</citedby><cites>FETCH-LOGICAL-c4056-fde37b5c4ba765d1f58e1bb70c0ac4d67606f54fc335f9ee096e4aab25bf73643</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-3148.2009.00946.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-3148.2009.00946.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19725902$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Bi-juan</creatorcontrib><creatorcontrib>Jiang, Yuan-jun</creatorcontrib><creatorcontrib>Yuan, Fen</creatorcontrib><creatorcontrib>Ye, Hong-xing</creatorcontrib><title>Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17</title><title>Transfusion medicine (Oxford, England)</title><addtitle>Transfus Med</addtitle><description>HDN attributed to the rare Rh variants has become more and more significant caused by anti‐D, but the compatible blood is usually very difficult to obtain when exchange transfusion is required. We treated a 10‐hour neonate of O, D + C + c − E − e + blood group with severe HDN due to anti‐Rh17 with least incompatible blood typed O, D + C − c + E + e −. The neonatal hemolysis was relieved obviously and bilirubin was reduced gradually after exchange transfusion. The infant was discharged in good health 13 days after birth with 135.0 g/L, 28.0 μmol/L and 10.7 μmol/L of Hb, total bilirubin and direct bilirubin, respectively. No sequelae were observed in a three‐year follow‐up. The result suggesting that the least incompatible blood is an alternative choice for exchange transfusion in severe HDN due to anti‐Rh17 in case that Rh17 antigen‐negative blood is unavailable.</description><subject>Adult</subject><subject>Blood Component Transfusion - methods</subject><subject>Blood Group Incompatibility - drug therapy</subject><subject>Blood Group Incompatibility - immunology</subject><subject>Blood Grouping and Crossmatching</subject><subject>Erythrocyte Transfusion</subject><subject>exchange transfusion</subject><subject>Female</subject><subject>HDN</subject><subject>Humans</subject><subject>Hydrops Fetalis - immunology</subject><subject>Hydrops Fetalis - therapy</subject><subject>Hyperbilirubinemia, Neonatal - etiology</subject><subject>Hyperbilirubinemia, Neonatal - radiotherapy</subject><subject>Hyperbilirubinemia, Neonatal - therapy</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Infant, Newborn</subject><subject>Isoantibodies - immunology</subject><subject>least incompatible blood</subject><subject>Leukocyte Reduction Procedures</subject><subject>Male</subject><subject>Methylprednisolone - therapeutic use</subject><subject>Plasma</subject><subject>Pregnancy</subject><subject>Rh Isoimmunization</subject><subject>Rh-Hr Blood-Group System - immunology</subject><subject>Rho(D) Immune Globulin</subject><subject>Ultraviolet Therapy</subject><subject>Young Adult</subject><issn>0958-7578</issn><issn>1365-3148</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkM1u3CAURlHUKpmmeYWIXVZ2wRiwpWyqdJK0SX9UpeoSAb5kmNpmCnYz8_a1O6NkW6QrkPjOd6WDEKYkp9N5t84pEzxjtKzygpA6n6YU-fYILZ4_XqEFqXmVSS6rE_QmpTUhlBV1cYxOaC0LXpNigbrl1q50_wh4iLpPbkw-9Dg43IJOA_a9Dd1GD960gE0bQoNdiDjBH4iAV9CFdjd4ixufpjzM4LAC3MOTCbHHzTj1Bqz7wWffV1S-Ra-dbhOcHe5T9ON6-XB1m91_vfl49f4-syXhInMNMGm4LY2WgjfU8QqoMZJYom3ZCCmIcLx0ljHuagBSCyi1NgU3TjJRslN0se_dxPB7hDSozicLbat7CGNSkrFKyLqak9U-aWNIKYJTm-g7HXeKEjW7Vms1K1WzUjW7Vv9cq-2Enh-WjKaD5gU8yJ0Cl_vAk29h99_F6uHzcnpMeLbHfRpg-4zr-EsJySRXP7_cKPLt0-3d3Qeprtlfv72dwg</recordid><startdate>201002</startdate><enddate>201002</enddate><creator>Li, Bi-juan</creator><creator>Jiang, Yuan-jun</creator><creator>Yuan, Fen</creator><creator>Ye, Hong-xing</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201002</creationdate><title>Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17</title><author>Li, Bi-juan ; Jiang, Yuan-jun ; Yuan, Fen ; Ye, Hong-xing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4056-fde37b5c4ba765d1f58e1bb70c0ac4d67606f54fc335f9ee096e4aab25bf73643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Blood Component Transfusion - methods</topic><topic>Blood Group Incompatibility - drug therapy</topic><topic>Blood Group Incompatibility - immunology</topic><topic>Blood Grouping and Crossmatching</topic><topic>Erythrocyte Transfusion</topic><topic>exchange transfusion</topic><topic>Female</topic><topic>HDN</topic><topic>Humans</topic><topic>Hydrops Fetalis - immunology</topic><topic>Hydrops Fetalis - therapy</topic><topic>Hyperbilirubinemia, Neonatal - etiology</topic><topic>Hyperbilirubinemia, Neonatal - radiotherapy</topic><topic>Hyperbilirubinemia, Neonatal - therapy</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Infant, Newborn</topic><topic>Isoantibodies - immunology</topic><topic>least incompatible blood</topic><topic>Leukocyte Reduction Procedures</topic><topic>Male</topic><topic>Methylprednisolone - therapeutic use</topic><topic>Plasma</topic><topic>Pregnancy</topic><topic>Rh Isoimmunization</topic><topic>Rh-Hr Blood-Group System - immunology</topic><topic>Rho(D) Immune Globulin</topic><topic>Ultraviolet Therapy</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Bi-juan</creatorcontrib><creatorcontrib>Jiang, Yuan-jun</creatorcontrib><creatorcontrib>Yuan, Fen</creatorcontrib><creatorcontrib>Ye, Hong-xing</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transfusion medicine (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Bi-juan</au><au>Jiang, Yuan-jun</au><au>Yuan, Fen</au><au>Ye, Hong-xing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17</atitle><jtitle>Transfusion medicine (Oxford, England)</jtitle><addtitle>Transfus Med</addtitle><date>2010-02</date><risdate>2010</risdate><volume>20</volume><issue>1</issue><spage>66</spage><epage>69</epage><pages>66-69</pages><issn>0958-7578</issn><eissn>1365-3148</eissn><abstract>HDN attributed to the rare Rh variants has become more and more significant caused by anti‐D, but the compatible blood is usually very difficult to obtain when exchange transfusion is required. We treated a 10‐hour neonate of O, D + C + c − E − e + blood group with severe HDN due to anti‐Rh17 with least incompatible blood typed O, D + C − c + E + e −. The neonatal hemolysis was relieved obviously and bilirubin was reduced gradually after exchange transfusion. The infant was discharged in good health 13 days after birth with 135.0 g/L, 28.0 μmol/L and 10.7 μmol/L of Hb, total bilirubin and direct bilirubin, respectively. No sequelae were observed in a three‐year follow‐up. The result suggesting that the least incompatible blood is an alternative choice for exchange transfusion in severe HDN due to anti‐Rh17 in case that Rh17 antigen‐negative blood is unavailable.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>19725902</pmid><doi>10.1111/j.1365-3148.2009.00946.x</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0958-7578 |
| ispartof | Transfusion medicine (Oxford, England), 2010-02, Vol.20 (1), p.66-69 |
| issn | 0958-7578 1365-3148 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_733867984 |
| source | MEDLINE; Wiley Online Library All Journals |
| subjects | Adult Blood Component Transfusion - methods Blood Group Incompatibility - drug therapy Blood Group Incompatibility - immunology Blood Grouping and Crossmatching Erythrocyte Transfusion exchange transfusion Female HDN Humans Hydrops Fetalis - immunology Hydrops Fetalis - therapy Hyperbilirubinemia, Neonatal - etiology Hyperbilirubinemia, Neonatal - radiotherapy Hyperbilirubinemia, Neonatal - therapy Immunoglobulins, Intravenous - therapeutic use Immunosuppressive Agents - therapeutic use Infant, Newborn Isoantibodies - immunology least incompatible blood Leukocyte Reduction Procedures Male Methylprednisolone - therapeutic use Plasma Pregnancy Rh Isoimmunization Rh-Hr Blood-Group System - immunology Rho(D) Immune Globulin Ultraviolet Therapy Young Adult |
| title | Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T17%3A40%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exchange%20transfusion%20of%20least%20incompatible%20blood%20for%20severe%20hemolytic%20disease%20of%20the%20newborn%20due%20to%20anti-Rh17&rft.jtitle=Transfusion%20medicine%20(Oxford,%20England)&rft.au=Li,%20Bi-juan&rft.date=2010-02&rft.volume=20&rft.issue=1&rft.spage=66&rft.epage=69&rft.pages=66-69&rft.issn=0958-7578&rft.eissn=1365-3148&rft_id=info:doi/10.1111/j.1365-3148.2009.00946.x&rft_dat=%3Cproquest_cross%3E733867984%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733867984&rft_id=info:pmid/19725902&rfr_iscdi=true |